Type of sarcoma: 
Locations: 
London

Unfortunately in April 2019, Tracon announced the termination of the TAPPAS trial for patients with advanced or metastatic angiosarcoma. The trial was stopped because the combination of TRC105 plus votrient (pazopanib) did not show a clinically meaningful efficacy.

Tracon’s official press release contains more information, and you can read it here: http://bit.ly/2VLvjjQ

If you have any questions or concerns about the termination of the trial, you can contact the Sarcoma UK Support Line on 0808 801 0401 or email supportline@sarcoma.org.uk.